While you are exactly correct, DRACO is proposed as a broad spectrum antiviral that keys in on viral replication and kills cells in that process. It has been shown effective against every virus it has been tested on, and yet has been passed over for funding of larger trials essential to proceeding to actual introduction to the public by pharmaceutical companies (the source of almost all funding for such trials today, when their malign influence on government agencies is accounted for) whose business model actually curing disease threatens.
I encourage everyone to have a look at the above link, and consider why no funding for this broad spectrum antiviral has been forthcoming.
Thanks!